Capricorn Fund Invests $22.4 Million in Axogen (AXGN) for Nerve Repair Technology
Capricorn Fund Managers Ltd invested $22.4 million in Axogen (AXGN) during Q1 2026, acquiring 687,600 shares. The investment represents 3.6% of the fund's U.S. equity assets and follows a significant 139.5% rise in Axogen's stock price over the past year. Axogen specializes in surgical solutions for peripheral nerve repair.
Tickers: $AXGN $BAC $CVNA $KKR
Topics: Axogen Capricorn Fund market movement SEC filing stock investment